Investors / Device of Tomorrow Capital
Device of Tomorrow Capital
Venture capital
Device of Tomorrow Capital is an early-stage investment fund focused on medical technology. It invests alongside strategic investors and venture capital firms and maintains a portfolio across early innovation and commercial growth stages.
Invests inHealthcare & Biotech
In its own wordsmedtechhealthcaremedical devicesneurotechearly stage
Your fit with Device of Tomorrow Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsDevice of Tomorrow Capital lists 12 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Creative Destruction Lab, Jumpspace Ventures and XEIA Venture Partners.
Counts come from funding rounds that name Device of Tomorrow Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Device of Tomorrow Capital's whole history. Rounds on record name 1 company; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 73th | 8% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Creative Destruction Lab | 2 |
| Jumpspace Ventures | 2 |
| XEIA Venture Partners | 2 |
| 3E Bioventures Capital | 1 |
| AIX Ventures | 1 |
| Alpha Edison | 1 |
| Alumni Ventures | 1 |
| Ambit Health Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers12100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Creative Destruction Lab
Compare Device of Tomorrow Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Device of Tomorrow Capital| Date | Company | Stage |
|---|---|---|
| 17 Dec 2025 | Series A |
Round details for Device of Tomorrow Capital
Amounts, full round histories and every co-investor in Device of Tomorrow Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Carlsmed develops personalized spinal surgery solutions using a technology platform and AI-enabled procedures | Healthcare & Biotech | Portfolio page | ||
| CranioSense is developing a portable system to help clinicians assess intracranial pressure non-invasively | Healthcare & Biotech | Portfolio page | ||
| EarlyDiagnostics is building a platform for human health by transforming cell-free DNA into molecular insights for early disease detection and health monitoring. | Healthcare & Biotech | Portfolio page | ||
| Glean provides urology testing technology, specifically a catheter-free and wire-free urodynamic system for diagnosing and monitoring bladder function. | Healthcare & Biotech | Portfolio page | ||
| ImmersiveTouch provides advanced surgical planning solutions through virtual and augmented reality technology for surgeons in hospitals and private practices. | Healthcare & Biotech | Portfolio page | ||
| Modality.ai redefines how neurological and psychiatric conditions are assessed in clinical research using a multimodal assessment platform. | Healthcare & Biotech | Portfolio page | ||
| Neurava develops an AI-powered wearable platform to monitor and alert for seizures and other risks associated with epilepsy | Healthcare & Biotech | Portfolio page | ||
| NeuroBionics develops neural interfaces using bioelectronic fibers for neuromodulation therapies and research applications | Healthcare & Biotech | Portfolio page | ||
| Smartlens Health develops and offers smart contact lenses and related technologies for continuous monitoring, diagnosis, and treatment optimization of ophthalmic diseases | Healthcare & Biotech | Portfolio page | ||
| Telesair supplies respiratory care devices, including the AVEA Disposable Expiratory Filter and the Bonhawa High Flow Respiratory Humidifier. | Healthcare & Biotech | Portfolio page | ||
| Vonova develops minimally invasive transvascular technology to treat chronic neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Wearlinq Labs develops and provides cardiac monitoring solutions, including a wireless, continuous, FDA-cleared 6-Lead ECG multimodal monitor. | Healthcare & Biotech | Dec 2025Series A | Page + round |
About this data
site last read 5 Nov 2026- Site
- deviceoftomorrow.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 17 Dec 2025
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Device of Tomorrow Capital's profile as data
Pull Device of Tomorrow Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/deviceoftomorrow.com
# also
GET /v1/firms/deviceoftomorrow.com/portfolio
GET /v1/firms/deviceoftomorrow.com/coinvestors
GET /v1/firms/deviceoftomorrow.com/news